Trastuzumab(Herceptin®) Pharmacokinetic ELISA
€780.00
In stock
SKU
EL-1611-201
INTRODUCTION
Trastuzumab (trade name Herceptin®) is indicated for the treatment of HER2-positive breast cancer, and adjuvant therapies for metastatic gastric cancer and gastroesophageal cancer. Serum concentration of trastuzumab may predict some clinical outcome during therapy. It is also possible that the surveillance of circulating trastuzumab concentration during therapy represents a direct factor for immunogenicity and some other side effects. Identification of biomarkers and risk factors for adverse drug reactions that might be related to serum concentrations, and maintaining the effective minimum concentration of trastuzumab in order to potentially avoid some side effects, might be beneficial using a reliable method.
The Trastuzumab ELISA kit is designed to measure trastuzumab with high specificity and enhanced sensitivity. The assay design utilizes a pair of antibodies that allows the detection of the whole trastuzumab molecule in biological matrices.
PRINCIPLE OF THE ASSAY
This assay employs the sandwich enzyme immunoassay technique. Anti-Trastuzumab is coated onto a 96 well microplate. Calibrator, quality control samples and test samples are pipetted into the appropriate wells. Trastuzumab present in biological matrices is bound by the immobilized capture antibody. After washing away any unbound substances, enzyme linked detection antibody is added to the wells. The plate is washed to remove any unbound antibody-enzyme reagent and a substrate solution is added to the wells for color development. The color development is proportional to the amount of Trastuzumab present in test samples.
Product Properties
Detection method: Peroxidase / OD450
Storage and stability: Stable at -20°C for 1 year
Safety Warnings and Precautions: Research Use Only. Follow instructions.
Precision : Intra-assay coefficient of variation (CV) <10%. Inter-assay CV <10%.
Detection limit : 1.25ng/ml
Each kit includes:
- Coated microtiter plate, 96 wells
- Calibrator diluent. - 1.8ml
- Calibrator (1000 ug/mL) - 12ul
- 10X wash buffer - 25ml
- Assay buffer - 50ml
- 1000X detection reagent - 17ul
- TMB - 12ml
- TMB stop solution - 12ml
- Plate sealers - 3
Product Properties
Detection method: Peroxidase / OD450
Storage and stability: Stable at -20°C for 1 year
Safety Warnings and Precautions: Research Use Only. Follow instructions.
Precision : Intra-assay coefficient of variation (CV) <10%. Inter-assay CV <10%.
Detection limit : 1.25ng/ml
Each kit includes:
- Coated microtiter plate, 96 wells
- Calibrator diluent. - 1.8ml
- Calibrator (1000 ug/mL) - 12ul
- 10X wash buffer - 25ml
- Assay buffer - 50ml
- 1000X detection reagent - 17ul
- TMB - 12ml
- TMB stop solution - 12ml
- Plate sealers - 3
Trastuzumab (trade name Herceptin®) is indicated for the treatment of HER2-positive breast cancer, and adjuvant therapies for metastatic gastric cancer and gastroesophageal cancer. Serum concentration of trastuzumab may predict some clinical outcome during therapy. It is also possible that the surveillance of circulating trastuzumab concentration during therapy represents a direct factor for immunogenicity and some other side effects. Identification of biomarkers and risk factors for adverse drug reactions that might be related to serum concentrations, and maintaining the effective minimum concentration of trastuzumab in order to potentially avoid some side effects, might be beneficial using a reliable method.
The Trastuzumab ELISA kit is designed to measure trastuzumab with high specificity and enhanced sensitivity. The assay design utilizes a pair of antibodies that allows the detection of the whole trastuzumab molecule in biological matrices.
PRINCIPLE OF THE ASSAY
This assay employs the sandwich enzyme immunoassay technique. Anti-Trastuzumab is coated onto a 96 well microplate. Calibrator, quality control samples and test samples are pipetted into the appropriate wells. Trastuzumab present in biological matrices is bound by the immobilized capture antibody. After washing away any unbound substances, enzyme linked detection antibody is added to the wells. The plate is washed to remove any unbound antibody-enzyme reagent and a substrate solution is added to the wells for color development. The color development is proportional to the amount of Trastuzumab present in test samples.
Product Properties
Detection method: Peroxidase / OD450
Storage and stability: Stable at -20°C for 1 year
Safety Warnings and Precautions: Research Use Only. Follow instructions.
Precision : Intra-assay coefficient of variation (CV) <10%. Inter-assay CV <10%.
Detection limit : 1.25ng/ml
Each kit includes:
- Coated microtiter plate, 96 wells
- Calibrator diluent. - 1.8ml
- Calibrator (1000 ug/mL) - 12ul
- 10X wash buffer - 25ml
- Assay buffer - 50ml
- 1000X detection reagent - 17ul
- TMB - 12ml
- TMB stop solution - 12ml
- Plate sealers - 3
Product Properties
Detection method: Peroxidase / OD450
Storage and stability: Stable at -20°C for 1 year
Safety Warnings and Precautions: Research Use Only. Follow instructions.
Precision : Intra-assay coefficient of variation (CV) <10%. Inter-assay CV <10%.
Detection limit : 1.25ng/ml
Each kit includes:
- Coated microtiter plate, 96 wells
- Calibrator diluent. - 1.8ml
- Calibrator (1000 ug/mL) - 12ul
- 10X wash buffer - 25ml
- Assay buffer - 50ml
- 1000X detection reagent - 17ul
- TMB - 12ml
- TMB stop solution - 12ml
- Plate sealers - 3
| Is Featured? | No |
|---|
Write Your Own Review